• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Avatrombopag Maleate
BioHub® Magnetic Separator
Avatrombopag
Ursodeoxycholic acid
Troxerutin
CytoLinX® BRTF Single-use Top-driven Bioreactor Bag

Shandong Kexing Bioproducts.,Co.,Ltd - Exhibitor Webinar

September 02, 2020

Tag: Exhibitor Webinar , VEC , CPHI China


Company Name：Shandong Kexing Bioproducts.,Co.,Ltd

Company Profile：Brief description of Shandong Kexing Bioproducts Co.,Ltd

Title：Brief description of Shandong Kexing Bioproducts Co.,Ltd

Speaker：Sophia Cheng

Position：Manager of International  Sales Center  Dept.3 , mainly responsible for the market development in South Asia, the Middle East and Africa for many years, and is familiar with International registration regulations and guidelines of biologicals.


For more information, click here to view my store.

Previous:SyncoZymes (Shanghai) Co., Ltd. - Exhibitor Webinar

Next:67 per cent experts to use decentralised clinical trials in near future due to COVID-19: GlobalData

Related News

What companies are developing CNS drugs in China?

ChatGTP/PharmaSourcesNovember 08, 2023

Several pharmaceutical and biotechnology companies in China are actively involved in the research and development of Central Nervous System (CNS) drugs.

Shanghai Dayou Chromatagraphy Technology Service Co., Ltd.——Professional chromatographic filler supplier for industrial scale production

PharmaSourcesMay 15, 2023

International Perspective, Cutting-edge Technology Learning - Entering into HongKe(虹科) Technology Co., Ltd.

PharmaSources.comMay 27, 2022

Shandong Kexing Bioproducts.,Co.,Ltd - Exhibitor Webinar | Pharmasources.com

Established For Non-Sterile API and Pharmaceutical Intermediates, Ningxia Taiyicin Biotech Co., LTD.

PharmaSources.comDecember 30, 2021

Ningxia Taiyicin founded in 2010, covering about 221.73 hectares of construction area with registered capital RMB 625 million, is mainly established for Non-sterile API and pharmaceutical intermediates.

You may like
More>>

Glivec

Glivec
Vecuronium Bromide

Vecuronium Bromide
Heating Incubator(natural convection)

Heating Incubator(natural convection)
Vecuronium Bromide(FDA)

Vecuronium Bromide(FDA)
CTDE-CF Series Spilt Type Convection Clean Oven

CTDE-CF Series Spilt Type Convection Clean Oven
Cefovecin sodium

Cefovecin sodium
Vecuronium bromide

Vecuronium bromide
Vecuronium Bromide

Vecuronium Bromide
Vecuronium (FDA)

Vecuronium (FDA)
Vecuronium Bromide for Injection 4mg, 10mg, 20mg

Vecuronium Bromide for Injection 4mg, 10mg, 20mg

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service